These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1544661)

  • 21. Imipramine and weight gain during the treatment of recurrent depression.
    Frank E; Kupfer DJ; Bulik CM; Levenson JA
    J Affect Disord; 1990 Nov; 20(3):165-72. PubMed ID: 2148336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Onset of the antidepressive effect of rolipram, an antidepressant with a new mechanism of action, in comparison with imipramine].
    Meya U; Fichte K
    Nervenarzt; 1991 May; 62(5):288-91. PubMed ID: 1865959
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression with physical symptoms: treating to remission.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 7():24-8. PubMed ID: 12755649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Pisa syndrome (pleurothotonus) during antidepressant therapy.
    Suzuki T; Kurita H; Hori T; Sasaki M; Baba A; Shiraishi H; Piletz JE
    Biol Psychiatry; 1997 Jan; 41(2):234-6. PubMed ID: 9018396
    [No Abstract]   [Full Text] [Related]  

  • 26. Duration of antidepressant drug treatment. What is an adequate trial?
    Quitkin FM; Rabkin JG; Ross D; McGrath PJ
    Arch Gen Psychiatry; 1984 Mar; 41(3):238-45. PubMed ID: 6367689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 28. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
    [No Abstract]   [Full Text] [Related]  

  • 29. [Practical considerations in initial treatment].
    Allilaire JF
    Encephale; 1995 Mar; 21 Spec No 2():23-9. PubMed ID: 7588174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.
    Lineberry CG; Johnston JA; Raymond RN; Samara B; Feighner JP; Harto NE; Granacher RP; Weisler RH; Carman JS; Boyer WF
    J Clin Psychiatry; 1990 May; 51(5):194-9. PubMed ID: 2110559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
    Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
    Mendels J; Johnston R; Mattes J; Riesenberg R
    Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Depressing data on depression].
    Heinzl S
    Med Monatsschr Pharm; 1995 Dec; 18(12):343. PubMed ID: 8569585
    [No Abstract]   [Full Text] [Related]  

  • 36. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-resistant depression.
    Simpson GM; Kessel JB
    Br J Psychiatry; 1991 Jul; 159():162-3. PubMed ID: 1888969
    [No Abstract]   [Full Text] [Related]  

  • 39. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine.
    Simpson GM; White KL; Boyd JL; Cooper TB; Halaris A; Wilson IC; Raman EJ; Ruther E
    Am J Psychiatry; 1982 Mar; 139(3):358-60. PubMed ID: 7036761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.